Common Equity: The sum of all common equity items.
Innate Pharma S.A. Sponsored ADR (IPHA) had Common Equity of $-47.10M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$22.79M |
|
$4.24M |
|
$17.59M |
|
$40.38M |
|
$38.20M |
|
$10.95M |
|
$49.27M |
|
$87.47M |
|
|
Common Equity |
$-47.10M |
$-47.10M |
|
$-47.10M |
|
93.92M |
|
| Cash Flow Statement Financials | |
$-24.47M |
|
$2.36M |
|
$-2.75M |
|
$32.66M |
|
$7.51M |
|
$-25.15M |
|
$1.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|